Does ROTIGOTINE Cause Salivary hypersecretion? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Salivary hypersecretion have been filed in association with ROTIGOTINE (Neupro). This represents 0.2% of all adverse event reports for ROTIGOTINE.
12
Reports of Salivary hypersecretion with ROTIGOTINE
0.2%
of all ROTIGOTINE reports
4
Deaths
1
Hospitalizations
How Dangerous Is Salivary hypersecretion From ROTIGOTINE?
Of the 12 reports, 4 (33.3%) resulted in death, 1 (8.3%) required hospitalization.
Is Salivary hypersecretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROTIGOTINE. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does ROTIGOTINE Cause?
Product adhesion issue (1,718)
Off label use (646)
Drug ineffective (632)
Death (595)
Parkinson's disease (419)
Fall (412)
Device adhesion issue (383)
Overdose (353)
Application site pruritus (334)
Application site erythema (330)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
RISPERIDONE (485)
OLANZAPINE (449)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
Which ROTIGOTINE Alternatives Have Lower Salivary hypersecretion Risk?
ROTIGOTINE vs ROXADUSTAT
ROTIGOTINE vs ROXICODONE
ROTIGOTINE vs ROXITHROMYCIN
ROTIGOTINE vs ROZANOLIXIZUMAB
ROTIGOTINE vs ROZANOLIXIZUMAB-NOLI